Palmitelaidic Acid-d13

Confirm delete?

Palmitelaidic Acid-d₁₃

Zoom

Cat No: 27713

Biochemicals - Isotopically Labeled Standards

Palmitelaidic acid-d13 is intended for use as an internal standard for the quantification of palmitelaidic acid (Item No. 9001798) by GC- or LC-MS. Palmitelaidic acid is a trans isomer of palmitoleic acid (Item Nos. 10009871
21911) and dietary fatty...

This product can only be bought through Cayman Chemical. Please contact us.

Product Overview
Data
Downloads
About Cayman

Territorial Availability: Available through Bertin Technologies only in France

Synonyms:

(9E)-hexadecenoic-11,11,12,12,13,13,14,14,15,15,16,16,16-d13 acid

Correlated keywords:

GCMS LCMS deuterated deuterium FA methyl palmitelaidate hecadecenoate 9E-hexadecenoic acid-d13

Product Overview:
Palmitelaidic acid-d13 is intended for use as an internal standard for the quantification of palmitelaidic acid (Item No. 9001798) by GC- or LC-MS. Palmitelaidic acid is a trans isomer of palmitoleic acid (Item Nos. 10009871
21911) and dietary fatty acid that has been found in dairy fat products and various partially hydrogenated oils.{54366,54368} It decreases nitric oxide (NO) production and levels of soluble E-selectin in isolated human aortic endothelial cells (HAECs) when used at a concentration of 20 µM.{54366} Palmitelaidic acid (49 µM) inhibits Sendai virus-induced hemolysis of isolated human erythrocytes.{54367} Increased serum levels of palmitelaidic acid are associated with higher levels of LDL, but lower levels of triglycerides, fasting insulin, blood pressure, and incidence of diabetes.{54368}

Size	500 µg
Shipping	dry ice
Molecular Formula	C₁₆H₁₇D₁₃O₂
SMILES	[2H]C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])C([2H])([2H])/C=C/CCCCCCCC(O)=O
Molecular Weight	267,5
Formulation	A solution in ethanol
Purity	≥99% deuterated forms (d1-d13)
Custom Code	3822.19
UNSPSC code	12352100

Technical File

MSDS

Click here to ask for your quote and get 15% off Cayman's products.

Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.

Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.

Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.

Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.

Accreditations
ISO/IEC 17025:2005
ISO Guide 34:2009

Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.